Human β-defessin 3: A novel antimicrobial peptide preferentially expressed in ulcerative celitis
Jan Wehkamp(Robert Bosch Hospital), Jens M. Schroeder(Christian-Albrechts-Universität zu Kiel), Klaus Fellermann(Apple (Israel)), Juergen Harder, Klaus Herrlinger(Robert Bosch Hospital), Birte von Meissner, Eduard F. Stange(John Radcliffe Hospital)
Cited by 1
Related Papers
Reduced Paneth cell α-defensins in ileal Crohn's disease
|Proceedings of the National Academy of Sciences|2005|969
NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression
|Gut|2004|798
A Chromosome 8 Gene-Cluster Polymorphism with Low Human Beta-Defensin 2 Gene Copy Number Predisposes to Crohn Disease of the Colon
|The American Journal of Human Genetics|2006|566
European evidence-based Consensus on the management of ulcerative colitis: Current management
|Journal of Crohn s and Colitis|2008|558